1. Effect of priming interval on reactogenicity, peak immunological response, and waning after homologous and heterologous COVID-19 vaccine schedules: exploratory analyses of Com-COV, a randomised control trial. Issue 11 (November 2022) Authors: Shaw, Robert H; Liu, Xinxue; Stuart, Arabella S V; Greenland, Melanie; Aley, Parvinder K; Andrews, Nick J; Cameron, J Claire; Charlton, Sue; Clutterbuck, Elizabeth A; Collins, Andrea M; Dejnirattisai, Wanwisa; Dinesh, Tanya; Faust, Saul N; Ferreira, Daniela M; Finn, Adam; Green, Christopher A; Ha... Journal: Lancet Issue: Volume 10:Issue 11(2022) Page Start: 1049 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Effectiveness and impact of a reduced infant schedule of 4CMenB vaccine against group B meningococcal disease in England: a national observational cohort study. Issue 10061 (3rd December 2016) Authors: Parikh, Sydel R; Andrews, Nick J; Beebeejaun, Kazim; Campbell, Helen; Ribeiro, Sonia; Ward, Charlotte; White, Joanne M; Borrow, Ray; Ramsay, Mary E; Ladhani, Shamez N Journal: Lancet Issue: Volume 388:Issue 10061(2016) Page Start: 2775 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Generation time of the alpha and delta SARS-CoV-2 variants: an epidemiological analysis. Issue 5 (May 2022) Authors: Hart, William S; Miller, Elizabeth; Andrews, Nick J; Waight, Pauline; Maini, Philip K; Funk, Sebastian; Thompson, Robin N Journal: Lancet infectious diseases Issue: Volume 22:Issue 5(2022) Page Start: 603 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Growing evidence supports 4CMenB effectiveness. Issue 4 (April 2018) Authors: Ladhani, Shamez N; Borrow, Ray; Andrews, Nick J Journal: Lancet infectious diseases Issue: Volume 18:Issue 4(2018) Page Start: 370 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis. Issue 7385 (15th February 2003) Authors: Ramsay, Mary E; Andrews, Nick J; Trotter, Caroline L; Kaczmarski, Edward B; Miller, Elizabeth Journal: BMJ Issue: Volume 326:Issue 7385(2003) Page Start: 365 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Immunogenicity of the UK group B meningococcal vaccine (4CMenB) schedule against groups B and C meningococcal strains (Sched3): outcomes of a multicentre, open-label, randomised controlled trial. Issue 5 (May 2021) Authors: Davis, Kimberly; Valente Pinto, Marta; Andrews, Nick J; Goldblatt, David; Borrow, Ray; Findlow, Helen; Southern, Jo; Partington, Jo; Plested, Emma; Patel, Sima; Holland, Ann; Matheson, Mary; England, Anna; Hallis, Bassam; Miller, Elizabeth; Snape, Matthew D Journal: Lancet infectious diseases Issue: Volume 21:Issue 5(2021) Page Start: 688 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial. Issue 10319 (1st January 2022) Authors: Stuart, Arabella S V; Shaw, Robert H; Liu, Xinxue; Greenland, Melanie; Aley, Parvinder K; Andrews, Nick J; Cameron, J C; Charlton, Sue; Clutterbuck, Elizabeth A; Collins, Andrea M; Darton, Tom; Dinesh, Tanya; Duncan, Christopher J A; England, Anna; Faust, Saul N; Ferreira, Daniela M; Finn, Adam; ... Journal: Lancet Issue: Volume 399:Issue 10319(2022) Page Start: 36 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Pneumococcal conjugate vaccine 13 delivered as one primary and one booster dose (1 + 1) compared with two primary doses and a booster (2 + 1) in UK infants: a multicentre, parallel group randomised controlled trial. Issue 2 (February 2018) Authors: Goldblatt, David; Southern, Jo; Andrews, Nick J; Burbidge, Polly; Partington, Jo; Roalfe, Lucy; Valente Pinto, Marta; Thalasselis, Vasilli; Plested, Emma; Richardson, Hayley; Snape, Matthew D; Miller, Elizabeth Journal: Lancet infectious diseases Issue: Volume 18:Issue 2(2018) Page Start: 171 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Rapid estimation of excess mortality: nowcasting during the heatwave alert in England and Wales in June 2011. Issue 10 (5th July 2012) Authors: Green, Helen K; Andrews, Nick J; Bickler, Graham; Pebody, Richard G Journal: Journal of epidemiology and community health Issue: Volume 66:Issue 10(2012) Page Start: 866 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial. Issue 10303 (4th September 2021) Authors: Liu, Xinxue; Shaw, Robert H; Stuart, Arabella S V; Greenland, Melanie; Aley, Parvinder K; Andrews, Nick J; Cameron, J Claire; Charlton, Sue; Clutterbuck, Elizabeth A; Collins, Andrea M; Dinesh, Tanya; England, Anna; Faust, Saul N; Ferreira, Daniela M; Finn, Adam; Green, Christopher A; Hallis, Bas... Journal: Lancet Issue: Volume 398:Issue 10303(2021) Page Start: 856 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗